This Biotech’s Mission Is To Go Global – And Revolutionize Cancer Treatment
“We have a $5 billion market cap now. The next stage is for us to get to $20 billion,” declares the chief executive of the…
3 Stock Tickers With Triple-Digit Upside Potential
A biopharmaceutical company focused on addressing unmet needs in the fields of severe burns and other hard-to-heal wounds and a second biopharmaceutical company focused on…
This Immuno-Oncology Stock Could Be A Compelling Short-Term Play (Or Long-Term Investment)
The clinical-stage biotech highlighted in today’s article – operating in the hot immuno-oncology sector – has both long-term and short-term bull cases to be made…
It’s A Stock Picker’s Market
“This is a market that favors stock picking over market timing and macro analysis,” advises the author of today’s article, who argues that “The business…
These 2 Biotechs Could Revolutionize Disease Treatment And Prevention – And Bring Big Rewards To Risk-Tolerant Investors
“One method of finding great stocks is to hunt down clinical stage companies with potential new treatment methods for diseases and ailments that affect large…
These 5 Stocks Are Popular With Robinhood Users And Analysts Alike
Of the most popular stocks on the Robinhood trading app, which boast the highest analyst ratings? Today’s article identifies the five most popular Robinhood stocks…
The Recent – And Future – Performance Of The Nasdaq Junior Biotechnology Index Amid The Coronavirus Pandemic
Noting that it launched against “perhaps the most consequential backdrop imaginable for the overall Biotech industry,” today’s article examines the recent performance of the Nasdaq…
A First-In-Kind Universal Influenza Vaccine Could Make This Small Biotech A Strong Buy
“Imagine the market for an influenza vaccine that would not require modifications each year to address annual mutations in the influenza virus, that brings about…
This Women’s Healthcare Stock Has Gone From Mistake To Contrarian Opportunity
The author of today’s article made a mistake when they previously went against their rules for trading a premium-priced biotech and jumped on a small-cap…
Charting Biotech’s Course
“Given the volatile nature of biotech, many active traders look to the charts of popular exchange-traded products and their top holdings for clues as to…